Automotive Sensors Market size to grow by USD 8.33 billion from 2022 to 2027, The market is fragmented due to the presence of prominent companies like Amphenol Corp., Aptiv Plc and Auto DITEX BG Ltd., and many more – Technavio
NEW YORK, Jan. 8, 2024 /PRNewswire/ — The automotive sensors market is estimated to grow by USD 8.33 billion from 2022 to 2027, growing at a CAGR of 6.12%. The automotive sensors market is fragmented owing to the presence of many global and regional companies. A few prominent companies tha
Amazing Thailand Countdown 2024: ICONSIAM’s Record-Breaking Fireworks and 3D Drone Show Illuminate the Sky over the Chao Phraya River
With over 11 million viewers from around the world, the $8.5-million event featured world-renowned K-Pop idols and Thai artists, a spectacular 3D drone show, and a record-breaking display of mesmerizing fireworks along the scenic Chao Phraya River. BANGKOK, Jan. 8, 2024 /PRNewswire/ — ICONSI
Arctech Expands footprint in Turkey: Signed A Strategic Partnership Agreement with Alpon Energy
ISTANBUL, Jan. 8, 2024 /PRNewswire/ — Arctech, the world’s leading solar tracking, racking and BIPV solutions provider, entered a strategic partnership agreement with Alpon Energy in Istanbul, Turkey. This successful agreement marks the expansion of Arctech’s footprint in Turkey. A
Clarios and Altris announce collaboration agreement to advance sustainable sodium-ion battery technology
Project will focus on low-voltage automotive applications LAS VEGAS and GLENDALE, Wis. and UPPSALA, Sweden, Jan. 8, 2024 /PRNewswire/ — Clarios, a global leader in advanced low-voltage battery solutions, and Altris, a pioneer in sustainable sodium-ion battery technology, announced they have c
Final LICY Investor Deadline: Bronstein, Gewirtz & Grossman LLC Announces that Li-Cycle Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, Jan. 8, 2024 /PRNewswire/ — Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Li-Cycle Holdings Corp. (“Li-Cycle” or “the Company”) (NYSE: LICY) and certain of its off
Assisted Reproductive Technology (ART) Market size to grow by USD 8.23 billion from 2022 to 2027, Europe to account for 32% of market growth – Technavio
NEW YORK, Jan. 8, 2024 /PRNewswire/ — The Assisted Reproductive Technology (ART) Market is expected to grow by USD 8.23 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 5.79% during the forecast period, according to Technavio Research. The marke
Orange Finances Money Mali and TerraPay Forge Strategic Partnership for Seamless Cross-border Payments
BAMAKO, Mali, Jan. 8, 2024 /PRNewswire/ — Orange Finances Money Mali, a leading Electronic Money Establishment and subsidiary of Orange Mali, is proud to announce a groundbreaking partnership with TerraPay, a global cross-border payments network with an extensive reach. This partnership marks
Vedanta’s Hindustan Zinc Ranks No. 1 in S&P Global Corporate Sustainability Assessment 2023
HZL & Vedanta become the only Indian companies in global top 10 in metal and mining sectorParent company Vedanta Ltd. secures 3rd position globally in the sector, moves up 3 ranks NEW DELHI, Jan. 8, 2024 /PRNewswire/ — Vedanta’s Hindustan Zinc (HZL), the world’s largest zinc, l
/R E P E A T — CUPE and Air Transat reach a tentative agreement/
MONTREAL, Jan. 8, 2024 /CNW/ – On Sunday evening, the Canadian Union of Public Employees (CUPE) concluded another tentative agreement aimed at renewing the collective agreement for the company’s 2,100 flight attendants. General meetings of the members will be held in the next few days to
Caliway Announces FDA Acceptance of CBL-514 IND Application for Placebo-Controlled Phase 2 Study to treat Dercum’s Disease
NEW TAIPEI CITY, Jan. 8, 2024 /PRNewswire/ — Caliway Biopharmaceuticals (Caliway) announced that the United States Food and Drug Administration (U.S. FDA) has accepted the CBL-514 Investigational New Drug (IND) application of CBL-0202 DD Phase 2 Study to treat Dercum’s Disease. Dercum&#
